SCHEMBL19334365

SCHEMBL19334365

CC(=O)NCCNS(=O)(=O)c1cccc2nsnc12

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.67
▸ SMN1; SMN2 Q16637 4/20 0.67
▸ KMT2A Q03164 2/20 0.61
▸ TSHR P16473 1/20 0.61
▸ LMNA P02545 2/20 0.60
▸ PKM P14618 1/20 0.60
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ GAA P10253 1/20 0.58
▸ MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534789 0.83 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2KMT2ATSHRGAA
SCHEMBL19334313 0.79 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2KMT2ATSHRLMNA
SCHEMBL23016797 0.79 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2KMT2ALMNAPKM
SCHEMBL15882764 0.75 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2KMT2AGAAMAPT
SCHEMBL15308195 0.75 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KMT2ATSHRLMNA
SCHEMBL11888598 0.75 CYP1A2 (0.74) ALDH1A1SMN1; SMN2KMT2ATSHRLMNA
SCHEMBL15353952 0.74 ALDH1A1 (0.81) ALDH1A1SMN1; SMN2KMT2ATSHRLMNA
SCHEMBL16000103 0.74 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2KMT2ACYP1A2CYP3A4
SCHEMBL12085541 0.73 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KMT2ATSHRLMNA
SCHEMBL21976700 0.73 CYP1A2 (0.69) ALDH1A1SMN1; SMN2KMT2ALMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 — — US disclosed
Send feedback